Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hochhauser

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Oncotarget|March 17, 2018
MEK inhibition leads to BRCA2 downregulation and sensitization to DNA damaging agents in pancreas and ovarian cancer modelsFrancesca Vena, Ruochen Jia, Arman Esfandiari, et al.
Cancer Research|February 12, 2015
Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian CancerCarla S Milagre, Ganga Gopinathan, Gemma Everitt, et al.
Cell|December 8, 2023
Trellis tree-based analysis reveals stromal regulation of patient-derived organoid drug responsesMaría Ramos Zapatero, Alexander Tong, James W Opzoomer, et al.
Scientific Reports|January 22, 2020
Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradationSylwia Jones, Peter J King, Costin N Antonescu, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|October 30, 2016
Modulation of topoisomerase IIα expression and chemosensitivity through targeted inhibition of NF-Y:DNA binding by a diamino p-anisyl-benzimidazole (Hx) polyamideLuke Pett, Konstantinos Kiakos, Vijay Satam, et al.
Bioorganic & Medicinal Chemistry Letters|May 31, 2021
Effects of N-terminus modified Hx-amides on DNA binding affinity, sequence specificity, cellular uptake, and gene expressionKonstantinos Kiakos, Vijay Satam, Pravin C Patil, et al.
Journal of Medicinal Chemistry|July 30, 2013
An extended pyrrolobenzodiazepine-polyamide conjugate with selectivity for a DNA sequence containing the ICB2 transcription factor binding siteFederico Brucoli, Rachel M Hawkins, Colin H James, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2019
Measurement of Tumor Antioxidant Capacity and Prediction of Chemotherapy Resistance in Preclinical Models of Ovarian Cancer by Positron Emission TomographyHannah E Greenwood, Patrick N McCormick, Thibault Gendron, et al.
Biochemistry|September 24, 2004
Targeting the inverted CCAAT box 2 in the topoisomerase IIalpha promoter by JH-37, an imidazole-pyrrole polyamide hairpin: design, synthesis, molecular biology, and biophysical studiesJames A Henry, N Minh Le, Binh Nguyen, et al.
Chembiochem : a European Journal of Chemical Biology|September 23, 2006
Synthesis and evaluation of an intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase IIalpha promoterLloyd V Flores, Andrew M Staples, Hilary Mackay, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Oncotarget|March 17, 2018
MEK inhibition leads to BRCA2 downregulation and sensitization to DNA damaging agents in pancreas and ovarian cancer modelsFrancesca Vena, Ruochen Jia, Arman Esfandiari, et al.
Cancer Research|February 12, 2015
Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian CancerCarla S Milagre, Ganga Gopinathan, Gemma Everitt, et al.
Cell|December 8, 2023
Trellis tree-based analysis reveals stromal regulation of patient-derived organoid drug responsesMaría Ramos Zapatero, Alexander Tong, James W Opzoomer, et al.
Scientific Reports|January 22, 2020
Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradationSylwia Jones, Peter J King, Costin N Antonescu, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|October 30, 2016
Modulation of topoisomerase IIα expression and chemosensitivity through targeted inhibition of NF-Y:DNA binding by a diamino p-anisyl-benzimidazole (Hx) polyamideLuke Pett, Konstantinos Kiakos, Vijay Satam, et al.
Bioorganic & Medicinal Chemistry Letters|May 31, 2021
Effects of N-terminus modified Hx-amides on DNA binding affinity, sequence specificity, cellular uptake, and gene expressionKonstantinos Kiakos, Vijay Satam, Pravin C Patil, et al.
Journal of Medicinal Chemistry|July 30, 2013
An extended pyrrolobenzodiazepine-polyamide conjugate with selectivity for a DNA sequence containing the ICB2 transcription factor binding siteFederico Brucoli, Rachel M Hawkins, Colin H James, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2019
Measurement of Tumor Antioxidant Capacity and Prediction of Chemotherapy Resistance in Preclinical Models of Ovarian Cancer by Positron Emission TomographyHannah E Greenwood, Patrick N McCormick, Thibault Gendron, et al.
Biochemistry|September 24, 2004
Targeting the inverted CCAAT box 2 in the topoisomerase IIalpha promoter by JH-37, an imidazole-pyrrole polyamide hairpin: design, synthesis, molecular biology, and biophysical studiesJames A Henry, N Minh Le, Binh Nguyen, et al.
Chembiochem : a European Journal of Chemical Biology|September 23, 2006
Synthesis and evaluation of an intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase IIalpha promoterLloyd V Flores, Andrew M Staples, Hilary Mackay, et al.
Pageof 7